HARVEY PARTNERS, LLC 13D and 13G filings for Harvard Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:10 pm Sale | 2025-03-31 | 13G | Harvard Bioscience, Inc. HBIO | HARVEY PARTNERS, LLC | 2,187,500 4.960% | -370,000 (-14.47%) | Filing |
| 2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | Harvard Bioscience, Inc. HBIO | HARVEY PARTNERS, LLC | 2,557,500 6.000% | -354,000 (-12.16%) | Filing |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | Harvard Bioscience, Inc. HBIO | HARVEY PARTNERS, LLC | 2,911,500 7.000% | 2,911,500 (New Position) | Filing |